Status:
COMPLETED
The Effect of Fibromyalgia Syndrome Accompanying Obstructive Sleep Apnea Syndrome on Clinical Findings
Lead Sponsor:
Kirsehir Ahi Evran Universitesi
Conditions:
Obstructive Sleep Apnea
Fibromyalgia
Eligibility:
All Genders
18-60 years
Brief Summary
Fibromyalgia Syndrome (FMS) is a chronic disease that lasts for at least three months and is characterized by various symptoms such as tender points, widespread pain in the musculoskeletal system, sle...
Detailed Description
Our research will be carried out on patients diagnosed with OSAS after being evaluated in the sleep laboratory of the Research Hospital Department of Chest Diseases. Fibromyalgia screening will be per...
Eligibility Criteria
Inclusion
- 18-60 years old 2. Diagnosed with OSAS in sleep laboratory examinations 3. Agree to participate in the study
Exclusion
- Pregnancy
- Neuropsychiatric disease
- Inflammatory Rheumatic Diseases
- Morbid obesity
- Using a device with a previous diagnosis of OSAS
Key Trial Info
Start Date :
April 8 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 28 2022
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT05367167
Start Date
April 8 2022
End Date
November 28 2022
Last Update
January 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahi Evran University
Kırşehir, City Centre, Turkey (Türkiye), 40100